Cargando…
ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling
BACKGROUND: Endothelial junctions control functions such as permeability, angiogenesis and contact inhibition. VE-Cadherin (VECad) is essential for the maintenance of intercellular contacts. In confluent endothelial monolayers, N-Cadherin (NCad) is mostly expressed on the apical and basal membrane,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015342/ https://www.ncbi.nlm.nih.gov/pubmed/24593809 http://dx.doi.org/10.1186/1478-811X-12-12 |
_version_ | 1782315322635714560 |
---|---|
author | Amsellem, Valerie Dryden, Nicola H Martinelli, Roberta Gavins, Felicity Almagro, Lourdes Osuna Birdsey, Graeme M Haskard, Dorian O Mason, Justin C Turowski, Patric Randi, Anna M |
author_facet | Amsellem, Valerie Dryden, Nicola H Martinelli, Roberta Gavins, Felicity Almagro, Lourdes Osuna Birdsey, Graeme M Haskard, Dorian O Mason, Justin C Turowski, Patric Randi, Anna M |
author_sort | Amsellem, Valerie |
collection | PubMed |
description | BACKGROUND: Endothelial junctions control functions such as permeability, angiogenesis and contact inhibition. VE-Cadherin (VECad) is essential for the maintenance of intercellular contacts. In confluent endothelial monolayers, N-Cadherin (NCad) is mostly expressed on the apical and basal membrane, but in the absence of VECad it localizes at junctions. Both cadherins are required for vascular development. The intercellular adhesion molecule (ICAM)-2, also localized at endothelial junctions, is involved in leukocyte recruitment and angiogenesis. RESULTS: In human umbilical vein endothelial cells (HUVEC), both VECad and NCad were found at nascent cell contacts of sub-confluent monolayers, but only VECad localized at the mature junctions of confluent monolayers. Inhibition of ICAM-2 expression by siRNA caused the appearance of small gaps at the junctions and a decrease in NCad junctional staining in sub-confluent monolayers. Endothelioma lines derived from WT or ICAM-2-deficient mice (IC2neg) lacked VECad and failed to form junctions, with loss of contact inhibition. Re-expression of full-length ICAM-2 (IC2 FL) in IC2neg cells restored contact inhibition through recruitment of NCad at the junctions. Mutant ICAM-2 lacking the binding site for ERM proteins (IC2 ΔERM) or the cytoplasmic tail (IC2 ΔTAIL) failed to restore junctions. ICAM-2-dependent Rac-1 activation was also decreased in these mutant cell lines. Barrier function, measured in vitro via transendothelial electrical resistance, was decreased in IC2neg cells, both in resting conditions and after thrombin stimulation. This was dependent on ICAM-2 signalling to the small GTPase Rac-1, since transendothelial electrical resistance of IC2neg cells was restored by constitutively active Rac-1. In vivo, thrombin-induced extravasation of FITC-labeled albumin measured by intravital fluorescence microscopy in the mouse cremaster muscle showed that permeability was increased in ICAM-2-deficient mice compared to controls. CONCLUSIONS: These results indicate that ICAM-2 regulates endothelial barrier function and permeability through a pathway involving N-Cadherin, ERMs and Rac-1. |
format | Online Article Text |
id | pubmed-4015342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40153422014-05-10 ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling Amsellem, Valerie Dryden, Nicola H Martinelli, Roberta Gavins, Felicity Almagro, Lourdes Osuna Birdsey, Graeme M Haskard, Dorian O Mason, Justin C Turowski, Patric Randi, Anna M Cell Commun Signal Research BACKGROUND: Endothelial junctions control functions such as permeability, angiogenesis and contact inhibition. VE-Cadherin (VECad) is essential for the maintenance of intercellular contacts. In confluent endothelial monolayers, N-Cadherin (NCad) is mostly expressed on the apical and basal membrane, but in the absence of VECad it localizes at junctions. Both cadherins are required for vascular development. The intercellular adhesion molecule (ICAM)-2, also localized at endothelial junctions, is involved in leukocyte recruitment and angiogenesis. RESULTS: In human umbilical vein endothelial cells (HUVEC), both VECad and NCad were found at nascent cell contacts of sub-confluent monolayers, but only VECad localized at the mature junctions of confluent monolayers. Inhibition of ICAM-2 expression by siRNA caused the appearance of small gaps at the junctions and a decrease in NCad junctional staining in sub-confluent monolayers. Endothelioma lines derived from WT or ICAM-2-deficient mice (IC2neg) lacked VECad and failed to form junctions, with loss of contact inhibition. Re-expression of full-length ICAM-2 (IC2 FL) in IC2neg cells restored contact inhibition through recruitment of NCad at the junctions. Mutant ICAM-2 lacking the binding site for ERM proteins (IC2 ΔERM) or the cytoplasmic tail (IC2 ΔTAIL) failed to restore junctions. ICAM-2-dependent Rac-1 activation was also decreased in these mutant cell lines. Barrier function, measured in vitro via transendothelial electrical resistance, was decreased in IC2neg cells, both in resting conditions and after thrombin stimulation. This was dependent on ICAM-2 signalling to the small GTPase Rac-1, since transendothelial electrical resistance of IC2neg cells was restored by constitutively active Rac-1. In vivo, thrombin-induced extravasation of FITC-labeled albumin measured by intravital fluorescence microscopy in the mouse cremaster muscle showed that permeability was increased in ICAM-2-deficient mice compared to controls. CONCLUSIONS: These results indicate that ICAM-2 regulates endothelial barrier function and permeability through a pathway involving N-Cadherin, ERMs and Rac-1. BioMed Central 2014-03-04 /pmc/articles/PMC4015342/ /pubmed/24593809 http://dx.doi.org/10.1186/1478-811X-12-12 Text en Copyright © 2014 Amsellem et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Amsellem, Valerie Dryden, Nicola H Martinelli, Roberta Gavins, Felicity Almagro, Lourdes Osuna Birdsey, Graeme M Haskard, Dorian O Mason, Justin C Turowski, Patric Randi, Anna M ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling |
title | ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling |
title_full | ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling |
title_fullStr | ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling |
title_full_unstemmed | ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling |
title_short | ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling |
title_sort | icam-2 regulates vascular permeability and n-cadherin localization through ezrin-radixin-moesin (erm) proteins and rac-1 signalling |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015342/ https://www.ncbi.nlm.nih.gov/pubmed/24593809 http://dx.doi.org/10.1186/1478-811X-12-12 |
work_keys_str_mv | AT amsellemvalerie icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT drydennicolah icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT martinelliroberta icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT gavinsfelicity icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT almagrolourdesosuna icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT birdseygraemem icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT haskarddoriano icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT masonjustinc icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT turowskipatric icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling AT randiannam icam2regulatesvascularpermeabilityandncadherinlocalizationthroughezrinradixinmoesinermproteinsandrac1signalling |